aod9604 side effects tolerability Peptide Who should not take AOD9604? AOD 9604: Peptide Claims vs

Not for medical or veterinary use

employed in osteoarthritis and cartilage regeneration research Pigs Used for pharmacokinetic profiling and oral bioavailability studies Cynomolgus monkeys 9-month chronic toxicology studies via oral gavage Human subjects Approximately 900 participants across six clinical trials examining safety and efficacy Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite over 25 years of research and extensive clinical testing, AOD-9604 faces substantial evidence gaps that have prevented therapeutic development

These products are not drugs, foods, cosmetics, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use

Steady daily dosing is the standard

Glutathione tripeptide antioxidant cross-referenced with 5-Amino-1MQ in redox and methyl-pool research

Nervous system effects: In rare cases, tingling, weakness, or numbness may occur